Sequent Scientific, an active pharmaceutical ingredient company having
presence in Human and Veterinary segments and Specialty chemicals, plans to
invest Rs 150 crore in three new therapeutic segments. The investments in these
new businesses will be made over the next two years.
The company is expected to set up three new facilities at a greenfield site
in Bangalore, for which it has signed a MoU with the Karnataka Government at the
Global Investors Meet on 3 June 2010.
Also See:
NMDC
to set up steel plant (4-June-10)